霉浆菌检测市场规模、份额、成长分析，按产品/服务、按方法、按应用、按最终用户、按地区 - 行业预测，2024-2031

2022年全球霉浆菌检测市场规模将为8.296亿美元，从2023年的91.1023亿美元增长到2031年的19.1178亿美元，并将在预测期内增长（2024-2024年），预计复合年增长率为9.72 % 2031）。

霉浆菌检测市场旨在为各领域检测和预防霉浆菌污染提供可靠、准确、高效的工具和服务。市场包括套件、试剂、仪器和软体等各种产品，以及测试、检验和咨询等化验服务。主要市场驱动因素包括对生物製药和细胞疗法的需求不断增长、对霉浆菌污染风险的认识不断提高以及测试技术的进步。严格的监管要求进一步推动了对强大检测解决方案的需求。然而，检测成本高、检测方法缺乏标准化、熟练劳动力缺乏等挑战阻碍了市场的发展。进一步的挑战包括需要持续创新、解决虚假结果和交叉反应等问题，以及适应不断变化的需求。成长机会包括开拓新技术、开拓新的地区和产业、将检验与其他品管系统结合、利用数位化和自动化趋势来提高效率和准确性。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 价值链分析
• 供应链分析

霉浆菌检测市场：依产品/服务分类

• 市场概况
• 测定、套件和试剂
  • NAT 测定、套件和试剂
  • 酵素结合免疫吸附测定、套件及试剂
  • 拆卸套件
  • 染色
  • 其他测定、套件及试剂
• 装置
• 服务

霉浆菌检测市场：依方法分类

• 市场概况
• 核酸检测
• 酵素免疫分析法
• 染色
• 其他技术

霉浆菌检测市场：依应用分类

• 市场概况
• 细胞株测试
• 病毒测试
• 生产结束时进行电池测试

霉浆菌测试市场：依最终用户分类

• 市场概况
• 製药和生物技术公司
• 药品委外研发机构
• 学术/研究机构
• 细胞库/实验室

霉浆菌检测市场规模：依地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Merck KGaA
• Roche Diagnostics（A Division of F. Hoffmann-La Roche Ltd.）
• Charles River Laboratories International, Inc.
• Lonza Group Ltd.
• Thermo Fisher Scientific, Inc.
• Eurofins Scientific Group
• Sartorius Stedim Biotech SA
• Agilent Technologies, Inc.
• Meridian Bioscience, Inc.
• American Type Culture Collection
• Bionique Testing Laboratories, Inc.
• InvivoGen
• PromoCell GmbH
• Biological Industries Israel Beit Haemek Ltd.
• Clongen Laboratories, LLC
• Creative Bioarray
• Nelson Laboratories Fairfield, Inc.（A Part of Sotera Health）
• Norgen Biotek Corporation
• Biotools B & M Labs, SA
• GenBio（A Part of ExonHit Therapeutics SA）
• GeneCopoeia, Inc.
• Minerva Biolabs GmbH
• Mycoplasma Experience
• Savyon Diagnostics
• ScienceCell Research Laboratories

Global Mycoplasma Testing Market size was valued at USD 829.6 million in 2022 and is poised to grow from USD 9110.23 million in 2023 to USD 1911.78 million by 2031, growing at a CAGR of 9.72% during the forecast period (2024-2031).

The mycoplasma testing market aims to deliver reliable, accurate, and efficient tools and services for detecting and preventing Mycoplasma contamination across various sectors. It includes a range of products such as kits, reagents, instruments, and software, alongside laboratory services like testing, validation, and consulting. Key drivers of the market include the rising demand for biopharmaceuticals and cell-based therapies, heightened awareness of mycoplasma contamination risks, and advancements in testing technologies. Stringent regulatory requirements further propel the need for robust testing solutions. However, challenges such as high testing costs, a lack of standardized methods, and limited skilled personnel hinder the market. Additionally, the need for continuous innovation, addressing issues like false results and cross-reactivity, and adapting to evolving demands pose significant challenges. Opportunities for growth include the development of new technologies, market expansion into new regions and industries, and integrating testing with other quality control systems, while leveraging trends in digitization and automation to improve efficiency and accuracy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mycoplasma Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mycoplasma Testing Market Segmental Analysis

Global Mycoplasma Testing Market is segmented by Product & Service, Technique, Application, End User, and Region. Based on Product & Service, the market is segmented into Assays, Kits, & Reagents (NAT Assays, Kits, & Reagents; Enzyme-Linked Immunosorbent Assays, Kits, & Reagents, Elimination Kits, Stains, Other Assays, Kits, & Reagents), Instruments, Services. Based on Technique, the market is segmented into Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay, Staining, Other Techniques. Based on Application, the market is segmented into Cell Line Testing, Virus Testing, End-Of-Production Cell Testing. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, Cell Banks & Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Mycoplasma Testing Market

As awareness of the risks and consequences associated with Mycoplasma contamination grows, so does the demand for Mycoplasma testing. Contamination can significantly impact experimental results, affecting the reliability of research findings and altering cellular behavior. Additionally, it poses health risks to researchers and patients, further underscoring the need for effective testing solutions to ensure accuracy and safety in various scientific and clinical settings.

Restraints in the Global Mycoplasma Testing Market

The high expense associated with mycoplasma testing products and services can pose a considerable obstacle for many customers, particularly in emerging markets or resource-limited environments. Costs can fluctuate based on the type of test, the complexity of the sample, and the test's sensitivity and specificity. Advanced methods, such as PCR-based assays or high-throughput sequencing, are especially costly and may be out of reach for some customers, further limiting accessibility.

Market Trends of the Global Mycoplasma Testing Market

The integration of Mycoplasma testing with other quality control and assurance systems, such as microbial identification, endotoxin testing, and bioburden testing, is increasingly common in the market. This trend enables customers to consolidate their testing processes, leading to more efficient workflows. By combining these tests, customers can achieve faster turnaround times and reduce overall testing costs, enhancing both operational efficiency and cost-effectiveness.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Supply Chain Analysis

Mycoplasma Testing Market, By Product & Service

• Market Overview
• Assays, Kits, & Reagents
  • NAT Assays, Kits, & Reagents
  • Enzyme-Linked Immunosorbent Assays, Kits, & Reagents
  • Elimination Kits
  • Stains
  • Other Assays, Kits, & Reagents
• Instruments
• Services

Mycoplasma Testing Market, By Technique

• Market Overview
• Nucleic Acid Testing
• Enzyme-Linked Immunosorbent Assay
• Staining
• Other Techniques

Mycoplasma Testing Market, By Application

• Market Overview
• Cell Line Testing
• Virus Testing
• End-Of-Production Cell Testing

Mycoplasma Testing Market, By End User

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes
• Cell Banks & Laboratories

Mycoplasma Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius Stedim Biotech S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Type Culture Collection
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionique Testing Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InvivoGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological Industries Israel Beit Haemek Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clongen Laboratories, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nelson Laboratories Fairfield, Inc. (A Part of Sotera Health)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotools B & M Labs, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenBio (A Part of ExonHit Therapeutics SA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneCopoeia, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Minerva Biolabs GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mycoplasma Experience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Savyon Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienceCell Research Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments